Healthcare -
Biotechnology - NASDAQ - US
$ 9.75
0.619 %
$ 752 M
Market Cap
-3.18
P/E
REPL - NET INCOME
Net Income REPL - Replimune Group, Inc.
-216 M
LAST VALUE
-35.21%
2 YEAR CAGR
-47.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR